Xconomy By: Bruce V. Bigelow The sale of Amira Pharmaceuticals will likely go down as one of the standout life sciences deals of 2011—it certainly ranks as one of the biggest payouts in San Diego, where Amira was founded in 2005.
PRNewswire Syndax Pharmaceuticals, Inc., a late-stage epigenetics oncology company, announced today that members of management will present at the following upcoming fall conferences:
BusinessWire Team will advance SHM-XELTM antibody platform to build therapeutic pipeline AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced that Carol G. Gallagher has joined its board of directors as Executive Chair. In addition, AnaptysBio has promoted Hamza Suria… Read More
Observed Clinical Activity Suggests OTO-104 Provides Clinically Meaningful Reduction in Vertigo Frequency and Improvement in Tinnitus San Diego, CA, September 29, 2011 — Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the… Read More
Successful completion of first year milestones demonstrates applicability of SHM platform to biodefense applications SAN DIEGO–(BUSINESS WIRE)–AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced that the Defense Advanced Research Projects Agency (DARPA) has extended its contract with AnaptysBio to… Read More
Boston Herald By Donna Goodison TechStars is now a more enriching experience for start-ups. The 14-week accelerator and seed-stage investment program will start offering each participating company an additional $100,000 in funding in the form of a convertible debt note.… Read More
Oncology Report Digital Network By: Susan London SAN FRANCISCO – Entinostat, a novel oral histone deacetylase inhibitor taken once weekly, may overcome resistance to hormonal therapy in breast cancer, the results of a randomized phase-II trial suggest.
San Diego Magazine By Erin Chambers Smith Where do you go after starting San Diego’s fasting growing company, then selling it for millions? If you’re 26 at the time, like Jon Carder was in 2006 when he sold online loan… Read More
Xconomy by Arlene Weintraub Just two months after reporting positive data from a clinical trial of its lead drug candidate in lung cancer, Waltham, MA-based Syndax said today that the same drug performed well in a Phase 2 breast cancer… Read More
PRNewswire – Entinostat in combination with exemestane prolonged progression-free survival – – Randomized, placebo-controlled data to be in an oral presentation at ASCO Breast Cancer Symposium 2011 – Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announced today that ENCORE… Read More
BusinessWire Success Fee Paid to AnaptysBio as Milestone Under Partnership SAN DIEGO, Calif. – AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the successful completion of a therapeutic antibody generation project with a leading global pharmaceutical company. This is… Read More
By Ryan Lawler GigOm Things are heating up in the social video recommendations space, as a number of startups seek to become the go-to place for discovering new content based on what their friends are watching. But one of the newest… Read More
– Oral presentation will take place Saturday, September 10, 2011 – PRNewswire Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announced today that safety and efficacy data from ENCORE 301 will be presented in an oral session at the ASCO… Read More
Mass High Tech by Rodney H. Brown Boston startup Nanigans Inc., barely a year old, has been chosen by Electronic Arts Inc. to supply its advertising platform for EA social games on Facebook, according to a release. In addition, Nanigans… Read More
VentureBeat by Dean Takahashi Nanigans said it has raised $3 million in a first round of funding for its Facebook advertising platform. Boston-based Nanigans has created a real-time bidding platform for Facebook that makes it a lot easier to maximize… Read More
Digital East Asia by Doug Herman After months of speculation leading U.S.-based social games developer Zynga has partnered with Chinese Web giant Tencent Holdings Limited (HKG: 0700 | (ADR) PINK: TCEHY) to launch a localized version of CityVille in China. This is a… Read More
Acquisition Marks Bristol-Myers Squibb’s Entrance into Fibrotic Diseases, an Area of High Unmet Need that is Complementary to Current Therapeutic Areas of Focus
+Plastic Electronics by Dan Rogers One of the top six manufacturers of smartphones worldwide has adopted a nanomaterial touchscreen from US firm Cambrios, signalling the success of disruptive, next-generation technologies in the touchscreens markets.
By David Milstead Regular readers of Vox know this column has been, shall we say, skeptical of stocks with sky-high valuations, particularly those from the social media set. LinkedIn? Overpriced at $35 (U.S.), much less the $120 it traded at on… Read More
Avalon Ventures Partner – Richard Levandov